Paras Healthcare’s Rs 1,450 crore IPO enters its final bidding day with a muted response, while a grey market premium of around 2% signals modest listing expectations. Retail investors have subscribed fully, but institutional demand remains subdued.
Paras Healthcare’s Rs 1,450 crore IPO enters its final bidding day with a muted response, while a grey market premium of around 2% signals modest listing expectations. Retail investors have subscribed fully, but institutional demand remains subdued.
<iframe src="https://hindustansphere.com/embed/cluster/13fa6e8578023bd36794437f999f10863f819242" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Paras Healthcare IPO Day 3: Check GMP, subscription status and key details"></iframe>
Paras Healthcare has launched its IPO, starting on October 21 and concluding on October 23. By October 22, participation had reached only 15% overall, yet retail investor involvement surged to 69%. The funds raised are intended for debt repayment and general corporate uses. In Fiscal Year 2026, Paras Healthcare reported a notable profit of Rs 44 crore. Shares are expected to be listed by October 28, 2026.
